Remission of giant lymph node hyperplasia with anemia after radiotherapy

Dennis D. Weisenburger, Richard L. Degowin, D. Phillip Gibson, James O. Armitage

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

We have described a 51‐year‐old patient with unresectable mesenteric giant lymph node hyperplasia of the plasma cell type, severe systemic manifestations, and profound anemia. Supression of erythropoiesis may have been related to the presence of a circulating erythropoietic inhibitor produced by the lymphoid tumor. Markedly elevated titers to Epstein‐Barr virus capsid antigen suggest that this virus may be important in the etiology of the abnormal lymphoid proliferation. The marked clinical response and decrease in the size of the tumor following irradiation suggests that radiation therapy may be an alternative form of treatment for similar patients with unresectable lesions. Cancer 44:457‐462, 1979.

Original languageEnglish (US)
Pages (from-to)457-462
Number of pages6
JournalCancer
Volume44
Issue number2
DOIs
StatePublished - Aug 1979

Fingerprint

Giant Lymph Node Hyperplasia
Anemia
Radiotherapy
Viruses
Neoplasms
Erythropoiesis
Capsid
Plasma Cells
Antigens
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Remission of giant lymph node hyperplasia with anemia after radiotherapy. / Weisenburger, Dennis D.; Degowin, Richard L.; Phillip Gibson, D.; Armitage, James O.

In: Cancer, Vol. 44, No. 2, 08.1979, p. 457-462.

Research output: Contribution to journalArticle

Weisenburger, Dennis D. ; Degowin, Richard L. ; Phillip Gibson, D. ; Armitage, James O. / Remission of giant lymph node hyperplasia with anemia after radiotherapy. In: Cancer. 1979 ; Vol. 44, No. 2. pp. 457-462.
@article{f3ba8f8b3e6f4252849c75a4521e984c,
title = "Remission of giant lymph node hyperplasia with anemia after radiotherapy",
abstract = "We have described a 51‐year‐old patient with unresectable mesenteric giant lymph node hyperplasia of the plasma cell type, severe systemic manifestations, and profound anemia. Supression of erythropoiesis may have been related to the presence of a circulating erythropoietic inhibitor produced by the lymphoid tumor. Markedly elevated titers to Epstein‐Barr virus capsid antigen suggest that this virus may be important in the etiology of the abnormal lymphoid proliferation. The marked clinical response and decrease in the size of the tumor following irradiation suggests that radiation therapy may be an alternative form of treatment for similar patients with unresectable lesions. Cancer 44:457‐462, 1979.",
author = "Weisenburger, {Dennis D.} and Degowin, {Richard L.} and {Phillip Gibson}, D. and Armitage, {James O.}",
year = "1979",
month = "8",
doi = "10.1002/1097-0142(197908)44:2<457::AID-CNCR2820440212>3.0.CO;2-4",
language = "English (US)",
volume = "44",
pages = "457--462",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Remission of giant lymph node hyperplasia with anemia after radiotherapy

AU - Weisenburger, Dennis D.

AU - Degowin, Richard L.

AU - Phillip Gibson, D.

AU - Armitage, James O.

PY - 1979/8

Y1 - 1979/8

N2 - We have described a 51‐year‐old patient with unresectable mesenteric giant lymph node hyperplasia of the plasma cell type, severe systemic manifestations, and profound anemia. Supression of erythropoiesis may have been related to the presence of a circulating erythropoietic inhibitor produced by the lymphoid tumor. Markedly elevated titers to Epstein‐Barr virus capsid antigen suggest that this virus may be important in the etiology of the abnormal lymphoid proliferation. The marked clinical response and decrease in the size of the tumor following irradiation suggests that radiation therapy may be an alternative form of treatment for similar patients with unresectable lesions. Cancer 44:457‐462, 1979.

AB - We have described a 51‐year‐old patient with unresectable mesenteric giant lymph node hyperplasia of the plasma cell type, severe systemic manifestations, and profound anemia. Supression of erythropoiesis may have been related to the presence of a circulating erythropoietic inhibitor produced by the lymphoid tumor. Markedly elevated titers to Epstein‐Barr virus capsid antigen suggest that this virus may be important in the etiology of the abnormal lymphoid proliferation. The marked clinical response and decrease in the size of the tumor following irradiation suggests that radiation therapy may be an alternative form of treatment for similar patients with unresectable lesions. Cancer 44:457‐462, 1979.

UR - http://www.scopus.com/inward/record.url?scp=0018669176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018669176&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197908)44:2<457::AID-CNCR2820440212>3.0.CO;2-4

DO - 10.1002/1097-0142(197908)44:2<457::AID-CNCR2820440212>3.0.CO;2-4

M3 - Article

C2 - 476562

AN - SCOPUS:0018669176

VL - 44

SP - 457

EP - 462

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -